Previous 10 | Next 10 |
Summary Shares of neuro-pharmaceutical concern Biohaven Ltd. (BHVN) have more than doubled after being spun out as part of Pfizer’s (PFE) purchase of the legacy company’s migraine assets. The one-month move was accomplished despite a secondary that diluted shareholders by ...
Biohaven press release ( NYSE: BHVN ): Q3 Non-GAAP EPS of -$1.25. Cash as of September 30, 2022 was $50.7 million, excluding $0.8 million of restricted cash, compared to $76.1 million as of December 31, 2021. For further details see: Biohaven Non-GAAP EPS of -$1....
Biohaven Ltd. Reports Third Quarter 2022 Financial Results and Reports Recent Business Developments PR Newswire Biohaven Ltd. launched post-closing of the Biohaven Pharmaceutical Holding Company Ltd. sale to Pfizer on October 4, 2022 , and completed a public offeri...
Summary The lazy way to interpret the tech titans earnings reports last week is to say that Cloud Tech is over. It's not. We organize post market trading we call "fishing" we use it to try and acquire shares at the lowest prices. Alphabet, Amazon, and Microsoft will regain the...
Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares PR Newswire NEW HAVEN, Conn. , Oct. 25, 2022 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) (the "Company" or "Biohaven") today announced...
Biohaven Advances Development of the MoDE Platform Technology Licensed From Yale University PR Newswire Biohaven advances development of its extracellular target degrader platform technology (MoDEs™) for therapies across a variety of diseases including neurosc...
Biohaven ( NYSE: BHVN ) has priced upsized public offering of 25M of its common shares, at a public offering price of $10.50/common share. Underwriters are granted a 30-day option to purchase up to an additional 3.75M common shares. Offering is expected to close on Oct...
Biohaven ( NYSE: BHVN ) on Tuesday announced a public offering of 20M shares, sending its shares 5.2% lower after the bell. Underwriters will get a 30-day option to buy up to an additional 3M shares. Biohaven ( BHVN ) will use the net proceeds from the offering...
Biohaven Announces Launch of Public Offering of Common Shares PR Newswire NEW HAVEN, Conn. , Oct. 18, 2022 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) ("Biohaven") announced today that it has commenced a public offering of 20,000,000 of its common shares p...
Summary I wanted to focus on an opportunity to acquire well-known big-cap names in the S&P 500 that, at this point, could provide "tech-like" returns. I attempt to explain these precipitous bear market rallies, and how we anticipate them. I also talk about a tactical shift...
News, Short Squeeze, Breakout and More Instantly...
Biohaven Pharmaceutical Holding Company Ltd. Company Name:
BHVN Stock Symbol:
NYSE Market:
2024-07-20 03:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-29 12:00:07 ET Brian Skorney from Robert W. Baird issued a price target of $58.00 for BHVN on 2024-05-29 09:57:00. The adjusted price target was set to $58.00. At the time of the announcement, BHVN was trading at $30.31. The overall price target consensus is at $...